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ABSTRACT
Background: Hydatid disease is an endemic condition in
several parts of the world. Owing to ease of travel, even
surgeons in nonendemic areas encounter the disease and
should be aware of its optimum treatment. A safe, new
method of laparoscopic management of hepatic hydatid
disease is described along with a review of the relevant
literature.
Methods: Sixty-six cases of hepatic hydatid disease were
operated on laparoscopically using the Palanivelu Hydatid
System. The special trocar-cannula system used and the
technique of operation are described.
Results: The majority of the patients presented with pain.
Most of the patients had only a single cyst. The right lobe
of the liver was most commonly involved. Cysts were
bilateral in 4 patients. In 83.3%, simply evacuation of the
hydatid cyst by the Palanivelu Hydatid System was done.
In 13.7%, this was followed by a left lobectomy, as the
cysts were large occupying almost the entire left lobe of
the liver. The remnant cavity was dealt with by omento-
plasty. The average follow-up period is 5.8 years. There
have been no recurrences to date.
Conclusion: We recommend Palanivelu Hydatid System
for management of hepatic hydatid disease. We have
found its efficacy to be optimum for preventing spillage,
evacuating hydatid cyst contents, performing transcystic
fenestration, and for dealing with cyst-biliary communica-
tions.
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INTRODUCTION
Hydatidosis is an endemic parasitic disease in Mediterra-
nean countries, North Africa, Turkey, the Middle East,
Australia, New Zealand, South America, Baltic areas, the
Philippines, Northern China, and the Indian subcontinent.
However, physicians and surgeons worldwide may en-
counter the disease sporadically because of increased
travel and immigration.1,2
It is caused by the parasite, Echinococcus granulosus,
which is a cestode that lives in the small intestine of dogs
and other canines. Eggs are eliminated in the feces and
when ingested, liberate their larvae in the duodenum of
an intermediate host. The intermediate host can be sheep/
goat (pastoral hydatidosis) or reindeer/moose/caribou
(sylvan hydatidosis). Humans are accidental intermediate
hosts. The larvae cross the intestinal wall and via the
portal system reach the hepatic sinusoids where they
develop into cysts. Some larvae are not filtered in the liver,
but remain in the blood to reach the next station, the
lungs. In addition, some may pass through the pulmonary
circulation and travel to other organs. Larva transported in
the mesenteric lymphatics are carried to the cisterna chili,
the thoracic duct, and into the general circulation, ending
up in a variety of distant sites.1,3
The most common site of occurrence of hydatid cysts in
humans is the liver (50% to 93%).1,4,5 Left untreated, the
cyst grows and follows one of several courses: forms
fistulas into adjacent organs or the biliary system, ruptures
into the peritoneal cavity causing seeding of multiple
daughter cysts throughout the peritoneal cavity, develop-
ing daughter cysts within or rarely dying de novo. Older
cysts have an increased risk of exogenous daughter cyst
formation, which is an important factor for recurrence of
disease after surgery.6,7
Different therapies have been suggested. Medical therapy
consists of albendazole alone or in combination with
praziquantel by which stabilization of the disease has
been reported.8–12 A variety of surgical operations have
been advocated from complete resection (eg, total peri-
cystectomy or hepatectomy) to minimally invasive proce-
dures (eg, percutaneous aspiration of cysts).6,13–17 The
World Health Organization (WHO) recommends percuta-
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SCIENTIFIC PAPERneous aspiration, irrigation and re-aspiration (the PAIR
approach).18 More recently, reports have been published
on laparoscopic surgery for hepatic hydatid cysts.19–25
However, fear of anaphylactic shock resulting from spill-
age of hydatid fluid during treatment by the minimally
invasive method may be discouraging a wider adoption of
this technique.26
This study evaluates the efficacy of a new trocar-cannula
system, the Palanivelu Hydatid System (PHS), specifically
designed to prevent spillage of hydatid fluid for laparo-
scopic management of hydatid cysts.
METHODS
In all patients, the diagnosis of echinococcal cyst was
based on history, physical examination, ultrasound (US),
and computed tomography (CT) scan. Ultrasound was
used for follow-up. All patients were treated with albenda-
zole 10 mg/kg/day for at least 2 weeks preoperatively and
continued postoperatively for 4 weeks. The exclusion
criteria were no informed consent; serious coagulation
abnormalities; known allergy to local anesthetics or al-
bendazole; deep-seated cysts; posteriorly located cysts
(segments I, VII and VIII); cysts less than 3cm in diameter;
pregnancy, or women who refused contraception for the
time of albendazole treatment; and cysts characterized by
a heterogeneous complex mass (Gharbi type 4) or a cal-
cified wall (Gharbi type 5).
The Palanivelu Hydatid System
The Palanivelu Hydatid System (PHS) consists of a trocar
and cannula along with 5-mm and 3-mm reducers. The
trocar is 29-cm long. It is hollow throughout its length to
accommodate a suction cannula. Its tip is pyramidal
shaped with each facet of the pyramid bearing a fenestra-
tion to enable any fluid leaking on its insertion to be
sucked into its hollow body by the cannula placed within.
Its long shaft also bears 2 fenestrations opposite each
other at a distance of 17 cm from the tip. The cannula is
26-cm long with an inner diameter of 12 mm. It has 2 side
channels, one for gas insufflation and another for suction.
The suction channel has an inner diameter of 10 mm. Its
outer nozzle is designed so that the suction tube can be fit
onto it in an airtight manner (Figure 1).
Technique
After introducing the camera port through the umbilicus
following creation of pneumoperitoneum, the hydatid
cyst is identified on the surface of the liver. Then, the PHS
trocar with cannula is introduced into the peritoneal cavity
directly over the hydatid cyst. Once inside the peritoneal
cavity, the trocar is removed and the cannula alone is
advanced till its tip is in total contact with the hydatid cyst
surface. Suction is applied through the side channel to
maintain the contact between the cyst and the cannula
opening. Thereafter, the trocar with a 5-mm suction noz-
zle inside connected to another suction machine is intro-
duced into the cannula and, by steady pressure, is pushed
into the cyst along with the cannula. Any fluid spillage on
puncture of the cyst wall is immediately suctioned either
into the body of the hollow trocar through its fenestrated
tip and then into the suction cannula or into the outer
cannula and thence, into the suction side-channel. Once
the PHS enters into the hydatid cyst, the trocar is removed
and the cavity is irrigated through the main channel while
continuous suction is simultaneously maintained all the
time. In this way, fragments of laminated membrane,
daughter cysts, and debris are easily removed. Once the
retaining fluid is clear, CO2 is insufflated at low pressure
(3mm Hg to 4 mm Hg), and the telescope is introduced
into the cavity through the cannula to visualize the interior
for any overt cyst-biliary communication. In the absence
of overt cyst-biliary communication (verified by the ab-
sence of bile staining in the suctioned fluid and nonvisu-
alization of the opening within the cyst cavity), 0.5%
cetrimide is instilled into the cyst cavity as a scolicidal
agent. After 10 minutes, the scolicidal agent is suctioned
and the cyst is marsupialized. In case of overt signs of
cyst-biliary communication, use of a scolicidal agent is
avoided and after marsupialization, the opening is sutured
closed with 3–0 Vicryl. Omentoplasty is done for all cases.
The drainage tube is kept near the cyst.
Figure 1. Palanivelu Hydatid System.
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weeks and 1, 3, 6, 12, 18, and 24 months. If clinically
indicated, US is repeated at shorter intervals. CT scan is
performed if any complication/recurrence is suspected.
The primary end points were defined as complete cyst
collapse by US at the end of the procedure, disappearance
of cyst cavity or at least 50% reduction in cyst size at
follow-up imaging, and disappearance of complications,
such as pain, cystobiliary fistulas, vascular or biliary com-
pression, and infection. The secondary end points of the
study were recurrence of cyst cavity to 50% of its initial
size, vascular or biliary compression, fistulas, pain, and
infection within 2 years after surgery, death, withdrawal
from the study, or loss to follow-up.
RESULTS
Since 1997, 66 patients have been operated on with PHS.
The distribution of the patients regarding age and sex is
summarized in Table 1.
The majority of patients (51.5%) presented with pain. The
mode of presentation of the patients is listed in Table 2.
Most of the patients (N60, 90.9%) had only a single cyst,
while 6 patients (9.1%) had 2 cysts. The right lobe of the
liver was more commonly involved (n36, 54.5%) than
was the left lobe (n26, 39.4%). Cysts were bilateral in 4
cases (6.1%). Fifty-four patients (81.9%) had uncompli-
cated cysts. Of the remaining, 9 patients (13.6%) pre-
sented with cyst-biliary communication, one (1.5%) was a
case of secondarily infected cyst and 2 cases (3%) were
recurrent cysts. Out of the recurrent cysts, one had re-
curred after a laparoscopic attempt at removal elsewhere,
while the other case was following open hydatid surgery
(Table 3).
In 55 patients (83.3%), simply evacuation of the hydatid
cyst by PHS was done. In 9 cases (13.7%), this was fol-
lowed by left lobectomy, as the cysts were large, occupy-
ing almost the entire left lobe of the liver. The hepatec-
tomy was performed laparoscopically using a Harmonic
scalpel. Transcystic fenestration of underlying cyst was
carried out in 2 (3%) of the 6 patients with multiple cysts
while the other 4 were dealt with by separate insertions of
PHS into individual cysts. The remnant cavity was treated
by omentoplasty (Table 4). Omentoplasty was performed
by inserting a plug of omentum into the remnant cavity
and suturing it intracorporeally with the edge of the cavity
with Vicryl 2–0 interrupted sutures.
The average duration of the surgery was 52 minutes
(range, 36 to 94). None of the patients experienced intra-
operative anaphylactic shock.
Postoperatively, 2 patients (3%) had infection, and 9 pa-
tients (13.7%) had a minor biliary leak that stopped drain-
ing by 5 days to 7 days (Table 5).
Table 1.
Age and Sex of 66 Patients Operated On With the Palanivelu
Hydatid System
Youngest Patient 14 years
Oldest Patient 64 years




Symptoms Leading to Discovery of Hydatid Disease
Abdominal Pain 34 (51.5%)
Nausea, Dyspepsia 15 (22.7%)
Abdominal Swelling/Mass 13 (19.7%)




Single Cyst 60 (90.9%)
Multiple Cysts 6 (9.1%)
Site—Right Lobe of Liver 36 (54.5%)
Site—Left Lobe of Liver 26 (39.4%)
Site—Bilateral 4 (6.1%)
Uncomplicated Cysts 54 (81.9%)
Complicated Cysts 12 (18.1%)
Cyst-Biliary Communication 9 (13.6%)
Secondary Infection 1 (1.5%)
Recurrent Cysts 2 (3%)
Table 4.
Type of Surgery
Evacuation and Marsupialisation 55 (83.3%)
Evacuation and Lobectomy 9 (13.7%)
Transcystic Fenestration 2 (3%)
Repeated Separate Insertion of Palanivelu
Hydatid System
4 (6%)
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in 52 patients with an average follow-up period of 5.8
years. There have been no recurrences to date.
DISCUSSION
Physicians worldwide should be aware of the presenta-
tion and management of hydatid disease, which is en-
demic to certain regions, as they may encounter it spo-
radically due to increased travel and migration.1 Though
the common mode of infection is the unhygienic practice
of consuming unwashed or improperly washed infected
raw fruits and vegetables, direct contact with infected
dogs is also another means of contracting the disease,
especially in children.28 The youngest patient in the study
was 14 years old though the average age of 38.6 years was
in keeping with the average age of presentation in en-
demic areas.29–32 However in nonendemic areas, all the
age groups are usually equally affected with the average
age of presentation being older.28,33 Males were predom-
inantly affected in the study though other studies have
reported equal infestation in both sexes28–30 or predomi-
nant female infestation.31,33 Abdominal pain was the most
common mode of presentation (51.5% of cases) in this
study, which has also been reported by other authors.31,33
Liver hydatidosis is one of the most common causes of
acute abdomen in endemic regions. Echinococcal infesta-
tion should be suspected in patients who present with an
abdominal mass, pain, fever, jaundice, or anaphylaxis.34
However, in nonendemic countries, most of the cases are
asymptomatic and are detected fortuitously.1,28,34
The most common pathology was a single cyst in the right
lobe of the liver. Similar findings have also been reported
by other authors.1,29,33 Ultrasonography and CT are both
effective imaging modalities for the detection of liver hy-
datid disease.28,34 US is particularly useful for the detection
of cystic membranes, septa, and hydatid sand, while CT
best demonstrates cyst wall calcification and cyst infec-
tion.35 Certain features in US, CT, or magnetic resonance
imaging (MRI) may warn of biliary communication or
impending cyst rupture.30,35 Biliary involvement may be
confirmed by MRI or endoscopic retrograde cholangiog-
raphy (ERC).1,34 Ultrasonographic appearances have also
formed the basis of classification of liver hydatid cysts by
various authorities like Gharbi,36 WHO,18 and Milicevic.37
Serologic tests have a sensitivity of 65% to 90%28,34 but are
not routinely performed in our institution.
Surgery remains the mainstay of treatment for hepatic
echinococcosis. Several nonsurgical options have been
explored. In endemic countries with scarce surgical re-
sources, a percutaneous approach of aspiration, injection
and reaspiration (PAIR) has been advocated by WHO in
select cases.18 Modifications of this technique have been
developed to address a few of its shortcomings. Saremi38
described a percutaneous approach in which a special
cutting instrument is used to fragment and evacuate
daughter cysts and laminated membrane while the cavity
is continuously irrigated with scolecidals. Percutaneous
evacuation of cyst content (PEVAC) using a large bore
catheter has been advocated by Schipper et al.6 Drug
therapy in the form of oral albendazole is given for spe-
cific conditions in liver hydatid, viz.1 widely disseminated
hydatid disease,2 localized disease in poor surgical risk
patients,3 ruptured cysts, and4 patients in whom signifi-
cant intraoperative spillage has occurred.34,37 A variety of
surgical procedures are done for hydatid cysts of the liver,
which are tailored to suit each individual case. These
include marsupialization, closed total cystectomy, partial
pericystectomy, partial pericystectomy with capitonnage,
modified capitonnage, partial pericystectomy with omen-
toplasty, and typical and atypical liver resections.1,28,34,37,39
The first report of laparoscopic treatment of hydatid cyst
of the liver was published in 199440 followed soon there-
after by the first report of anaphylactic shock complicating
laparoscopic treatment of hydatid cysts of the liver.41 In
fact, an exaggerated fear of anaphylaxis seemed to dis-
courage surgeons from more widely adopting minimal
access techniques for the treatment of hydatid cysts.26
However, gradually reports started appearing in the world
literature detailing laparoscopic management of liver hy-









* Classification by Clavien et al.27 Grade I: alterations from the
ideal postoperative course, nonlife-threatening and with no last-
ing disability. Complications of this grade necessitate only bed-
side procedures and do not significantly extend hospital stay.
Grade II: complications that are potentially life-threatening but
without residual disability. A subdivision is made according to
the requirement for invasive procedures (IIB). Grade III: com-
plications resulting in residual long-term disability, including
organ resection or persistence of life-threatening conditions.
Grade IV: complications leading to patient death.
JSLS (2006)10:56–62 59advantages, and disadvantages of this technique have
been elucidated46,47 In our study, we have performed
various procedures laparoscopically, viz, evacuation and
marsupialization, transcystic fenestration, and left lobec-
tomy. The indications of these procedures are summa-
rized in Table 6. The remnant cyst was dealt with by
omentoplasty. We have used the Palanivelu Hydatid Sys-
tem (PHS), a specially designed trocar to obtain a totally
contamination-free management of liver hydatid disease.
Various laparoscopic techniques described are total peri-
cystectomy, puncture and aspiration of contents followed
by marsupialization, unroofing and drainage, unroofing
and omentoplasty, and omentoplasty using helical fasten-
ers.22,24,42,43,45,47–49 One of the problems faced in laparo-
scopic treatment of liver hydatid cysts is the difficulty in
evacuating the particulate contents of the cyst, the daugh-
ter cysts, and laminated membrane. Various instruments
have been described to evacuate the contents of hydatid
cysts.21,50–55 Bickel et al21 initially advocated the use of a
large transparent beveled cannula. Later on, they modified
the technique somewhat by creating a continuous vacuum
inside the cannula while its tip was firmly adhered to the
cyst wall.50 Saglam51 described a perforator-grinder-aspi-
rator apparatus designed specifically for the evacuation of
hydatid cysts. A similar aspirator-grinder apparatus was
described by Alper et al.52 Kayaalp53 directly inserted a
laparoscopic trocar into the hydatid cyst but reported
greater success for anterior and unilocular cysts than for
posterior and multi-locular cysts. Al-Shareef et al54 used a
liposuction cannula to evacuate hydatid cysts. Zengin et
al55 used another perforator and aspirator called the “per-
fore-aspirator.” Of all these, the isolated hypobaric tech-
nique described by Bickel et al50 is the only one that has
attempted to deal with the problem of spillage. PHS not
only prevents any spillage of hydatid fluid but also assists
complete evacuation of the cyst content and allows intra-
cystic magnified visualization for cyst-biliary communica-
tion. We have not had any experience with the devices
advocated by other authors.
Postoperatively, 2 of our patients had infections (Clavien
type I complication), while 9 of the patients had minor
biliary leakage (Clavien type II complication). All the in-
fections and leakages responded to conservative manage-
ment. Complications seen in open surgery include pleural
effusions, infections, biliary fistulae, subdiaphragmatic
collection, liver abcesses.5,37 Thus, with laparoscopic
management, the severity of complications decreases as
compared with that in open surgery.
With an average follow-up of 5.8 years, we have not had
any recurrences. Various reports in the literature reveal a
recurrence rate varying from 0.9% to 22% for open sur-
gery.56,57 Adequate data are absent from the literature
regarding recurrence following the minimally invasive ap-
proach.
We have found PHS highly effective and safe for the
laparoscopic management of hydatid disease. Due to the
freedom from spillage of hydatid fluid, the risk of anaphy-
lactic shock is minimal.
CONCLUSION
We recommend PHS for management of hepatic hydatid
disease. We have found its efficacy to be optimum for
preventing spillage, evacuating contents of hydatid cysts,
performing transcystic fenestration, and for dealing with
cyst-biliary communications. The only limitation of this
system is related to the anatomical relation of the cyst. At
present, we do not recommend this technique for poste-
riorly located cysts, small cysts, and cysts deep within the
hepatic parenchyma.
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